ArticleResearch and practice in thrombosis and haemostasis2025

Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial.

Zhengping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.